REGN US75886F1075

Report

Delayed Nasdaq - 01/20 04:00:01 pm
614.38	USD		-0.60%

12:01p	Forty Accomplished Young Scientists Named Finalists in the 2022 Regeneron Science Talent Search	PR
09:31a	Fda accepts for review libtayo in combination with chemotherapy for first-line treatment of advanced nsclc	AQ
01/19	Regeneron Says US FDA Accepts for Review its Supplemental BLA for Libtayo in Combination With Chemotherapy	MT

Calendar

Event chart REGENERON PHARMACEUTICALS

Upcoming events on REGENERON PHARMACEUTICALS

02/04/22		FY 2021 Earnings Release
02/04/22 \| 08:30am		FY 2021 Earnings Call
05/05/22		Q1 2022 Earnings Release (Projected)
08/04/22		Interim 2022 Earnings Release (Projected)
11/08/22		Q3 2022 Earnings Release (Projected)
02/09/23		FY 2022 Earnings Release (Projected)

Past events on REGENERON PHARMACEUTICALS

01/10/22 \| 10:30am		JP Morgan Healthcare Conference
12/13/21 \| 06:00pm		American Society of Hematology Virtual Meeting and Exposition - Poster No - 4111
12/13/21 \| 04:30pm		American Society of Hematology Virtual Meeting and Exposition
12/13/21		Revolutionizing Atopic Dermatitis Conference
12/12/21 \| 06:00pm		American Society of Hematology Virtual Meeting and Exposition - Poster No - 1998
12/11/21 \| 05:30pm		American Society of Hematology Virtual Meeting and Exposition - Poster No - 1128
12/11/21 \| 12:45pm		American Society of Hematology Virtual Meeting and Exposition - Oral No - 160
12/06/21 \| 02:00pm		H.C. WAINWRIGHT & Co. Virtual Conference - Fireside Chat
12/01/21 \| 08:00am		Piper Sandler Healthcare Conference
11/30/21 \| 09:15am		Evercore ISI HealthCONx Conference

Past dividends on REGENERON PHARMACEUTICALS

- No events available -

Annual results

Fiscal Period : December		2016	2017	2018	2019	2020	2021
Sales M $	Released Forecast Spread	4 860 4 923 -1,3%	5 872 5 788 1,5%	6 711 6 520 2,9%	7 863 7 816 0,61%	8 497 8 494 0,04%	15 515
Operating income (EBITDA) M $	Released Forecast Spread	1 435 1 470 -2,3%	2 732 2 658 2,8%	3 110 2 959 5,1%	3 420 3 610 -5,3%	4 245 4 158 2,1%	9 618
Operating profit (EBIT) M $	Released Forecast Spread	1 331 1 351 -1,5%	2 080 2 094 -0,70%	2 534 2 424 4,5%	2 210 2 285 -3,3%	3 577 3 485 2,6%	8 981
Pre-Tax Profit (EBT) M $	Released Forecast Spread	1 330 1 357 -2,0%	2 079 2 075 0,16%	2 554 2 543 0,39%	2 429 2 308 5,3%	3 810 3 582 6,4%	9 334
Net income M $	Released Forecast Spread	896 894 0,12%	1 199 1 438 -17%	2 444 2 257 8,3%	2 116 1 998 5,9%	3 513 3 160 11%	7 967
EPS $	Released Forecast Spread	7,70 7,66 0,51%	10,3 12,6 -18%	21,3 19,7 7,9%	18,5 17,6 4,7%	30,5 28,0 9,0%	70,4
Announcement Date		02/09/2017	02/08/2018	02/06/2019	02/06/2020	02/05/2021	-

Quarterly results

Fiscal Period : December

2020 Q3

2020 Q4

2021 Q1

2021 Q2

2021 Q3

2021 Q4

Sales
M $

Released
Forecast
Spread

2 294
2 085
10%

2 423
2 402
0,88%

2 529
2 561
-1,3%

5 139
3 972
29%

3 453
2 800
23%

4 383

Operating income
(EBITDA)
M $

Released
Forecast
Spread

1 112
907
23%

1 229
1 194
2,9%

1 311
1 118
17%

3 564
2 813
27%

2 057
1 314
57%

2 564

Operating profit
(EBIT)
M $

Released
Forecast
Spread

1 053
850
24%

1 167
991
18%

1 113
1 040
7,0%

3 347
1 949
72%

1 847
1 278
45%

2 576

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

998
861
16%

1 225
898
36%

1 253
1 079
16%

3 753
1 872
100%

1 817
1 392
30%

2 587

Net income
M $

Released
Forecast
Spread

842
713
18%

1 149
802
43%

1 115
953
17%

3 099
1 653
88%

1 632
1 152
42%

2 100

EPS
$

Released
Forecast
Spread

7,39
6,35
16%

10,2
7,11
44%

10,1
8,31
21%

28,0
16,0
75%

14,3
10,7
34%

18,6

Announcement Date

11/05/2020

02/05/2021

05/06/2021

08/05/2021

11/04/2021

Previous year

Next Year

Upcoming sector events for REGENERON PHARMACEUTICALS

02/02/22		VERTEX PHARMACEUTICALS : FY 2021 Earnings Release (Projected)
02/08/22		GILEAD SCIENCES, INC. : FY 2021 Earnings Release (Projected)
03/30/22		WUXI APPTEC CO., LTD. : FY 2021 Earnings Release (Projected)
04/05/22		BIONTECH SE : FY 2021 Earnings Release (Projected)
04/28/22		VERTEX PHARMACEUTICALS : Q1 2022 Earnings Release (Projected)
05/03/22		WUXI APPTEC CO., LTD. : Q1 2022 Earnings Release (Projected)
05/03/22		GILEAD SCIENCES, INC. : Q1 2022 Earnings Release (Projected)
05/17/22		BIONTECH SE : Q1 2022 Earnings Release (Projected)
07/27/22		VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected)
07/27/22		GILEAD SCIENCES, INC. : Interim 2022 Earnings Release (Projected)

More events

Past sector events for REGENERON PHARMACEUTICALS

11/09/21 \| 06:45am		BIONTECH SE : Q3 2021 Earnings Release
11/02/21 \| 03:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Q3 2021 Earnings Release
10/29/21 \| 05:41am		WUXI APPTEC CO., LTD. : Q3 2021 Earnings Release
10/28/21 \| 04:02pm		GILEAD SCIENCES, INC. : Q3 2021 Earnings Release
08/12/21 \| 05:52am		WUXI APPTEC CO., LTD. : Interim 2021 Earnings Release
08/09/21 \| 07:00am		BIONTECH SE : Interim 2021 Earnings Release
07/29/21 \| 04:01pm		GILEAD SCIENCES, INC. : Interim 2021 Earnings Release
07/29/21 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Interim 2021 Earnings Release
05/10/21 \| 07:00am		BIONTECH SE : Q1 2021 Earnings Release
04/29/21 \| 04:01pm		VERTEX PHARMACEUTICALS : Q1 2021 Earnings Release

More events

Analysis

Officials offer vaccine reassurance; WHO advises against travel bans